Cambridge Investment Research Advisors, Inc. Beyond Air, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Beyond Air, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,600 shares of XAIR stock, worth $4,408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,600Holding current value
$4,408% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XAIR
# of Institutions
50Shares Held
20.4MCall Options Held
31.2KPut Options Held
2.7K-
Alyeska Investment Group, L.P. Chicago, IL7.14MShares$2.71 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL3.33MShares$1.27 Million0.0% of portfolio
-
Lasry Marc New York, NY2.79MShares$1.06 Million12.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$480,5150.0% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1MShares$380,0000.01% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $11.4M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...